Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Should Antibacterials Be Deregulated?

April 26, 2017antibacterials deregulated

0

Posted

Should Antibacterials Be Deregulated?

1 Answer

0

Posted

Author InfoJoan Rovira (Soikos Centre d’ Estudis en Economia de la Salut i Politica Social S.L., Barcelona, Spain) Montserrat Figueras (Soikos Centre d’ Estudis en Economia de la Salut i Politica Social S.L., Barcelona, Spain) Josep L. Segu (Soikos Centre d’ Estudis en Economia de la Salut i Politica Social S.L., Barcelona, Spain) Abstract Deregulation of antibacterials is a recurrent topic in the debate on pharmaceutical policy. This article focuses on one aspect of pharmaceutical regulation, namely the requirement of a medical prescription for purchasing antibacterials. However, a strategy of deregulation should not only concern the switch from prescription-only status to nonprescription status for a given drug, but should consider some complementary measures to minimise potentially harmful effects on health and costs. Risk-benefit and economic evaluations, which are possible approaches to assess the convenience of antibacterial deregulation, force the empirical evidence, the assumpt